Search Results - "MOHTY, Mohamad"

FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions by Antar, Ahmad I., Otrock, Zaher K., Jabbour, Elias, Mohty, Mohamad, Bazarbachi, Ali

“…The FMS-like tyrosine kinase 3 (FLT3) gene is mutated in approximately one third of patients with acute myeloid leukemia (AML), either by internal tandem…”
Get full text

Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease by Zeiser, Robert, von Bubnoff, Nikolas, Butler, Jason, Mohty, Mohamad, Niederwieser, Dietger, Or, Reuven, Szer, Jeff, Wagner, Eva M, Zuckerman, Tsila, Mahuzier, Bruyère, Xu, Judith, Wilke, Celine, Gandhi, Kunal K, Socié, Gérard

“…When acute GVHD is refractory to glucocorticoids, no consensus exists on the best therapy. In a phase 3, randomized trial, ruxolitinib led to a response in 62%…”
Get full text

Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities by Al Hamed, Rama, Bazarbachi, Abdul Hamid, Mohty, Mohamad

“…Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the population worldwide. The virus can establish a lifelong latent…”
Get full text

Introduction to host microbiome symbiosis in health and disease by Malard, Florent, Dore, Joel, Gaugler, Béatrice, Mohty, Mohamad

“…Humans share a core intestinal microbiome and yet human microbiome differs by genes, species, enterotypes (ecology), and gene count (microbial diversity)…”
Get full text

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years by Passweg, Jakob R., Baldomero, Helen, Chabannon, Christian, Basak, Grzegorz W., de la Cámara, Rafael, Corbacioglu, Selim, Dolstra, Harry, Duarte, Rafael, Glass, Bertram, Greco, Raffaella, Lankester, Arjan C., Mohty, Mohamad, Peffault de Latour, Régis, Snowden, John A., Yakoub-Agha, Ibrahim, Kröger, Nicolaus

“…Numbers of Hematopoietic cell transplantation (HCT) in Europe and collaborating countries continues to rise with 48,512 HCT in 43,581 patients, comprising of…”
Get full text

In 2022, which is preferred: haploidentical or cord transplant? by Nagler, Arnon, Mohty, Mohamad

“…Allogeneic hematopoietic stem cell transplantation is the treatment of choice for high-risk hematological malignancies such as acute myeloid and lymphocytic…”
Get full text

Current status of autologous stem cell transplantation for multiple myeloma by Al Hamed, Rama, Bazarbachi, Abdul Hamid, Malard, Florent, Harousseau, Jean-Luc, Mohty, Mohamad

“…More than 30 years after its introduction, autologous stem cell transplantation (ASCT) remains the standard of care for young patients with newly diagnosed…”
Get full text

Relapsed refractory multiple myeloma: a comprehensive overview by Bazarbachi, Abdul Hamid, Al Hamed, Rama, Malard, Florent, Harousseau, Jean-Luc, Mohty, Mohamad

“…Most patients with relapsed/refractory multiple myeloma (RRMM) have been treated with drug combinations including a proteasome inhibitor (PI) and/or an…”
Get full text

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation by Ciurea, Stefan O., Al Malki, Monzr M., Kongtim, Piyanuch, Fuchs, Ephraim J., Luznik, Leo, Huang, Xiao-Jun, Ciceri, Fabio, Locatelli, Franco, Aversa, Franco, Castagna, Luca, Bacigalupo, Andrea, Martelli, Massimo, Blaise, Didier, Ben Soussan, Patrick, Arnault, Yolande, Handgretinger, Rupert, Roy, Denis-Claude, O’Donnell, Paul V., Bashey, Asad, Solomon, Scott, Romee, Rizwan, Gayoso, Jorge, Lazarus, Hillard M., Ballen, Karen, Savani, Bipin N., Mohty, Mohamad, Nagler, Arnon

“…The number of HLA-haploidentical hematopoietic cell transplants continues to increase worldwide due to recent improvements in outcomes, allowing more patients…”
Get full text

Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel by Bonifazi, Francesca, Rubio, Marie-Thérèse, Bacigalupo, Andrea, Boelens, Jaap Jan, Finke, Jürgen, Greinix, Hildegard, Mohty, Mohamad, Nagler, Arnon, Passweg, Jakob, Rambaldi, Alessandro, Socie, Gérard, Solano, Carlos, Walker, Irwin, Barosi, Giovanni, Kröger, Nicolaus

“…This collaborative initiative aimed to provide recommendations on the use of polyclonal antithymocyte globulin (ATG) or anti-T lymphocyte globulin (ATLG) for…”
Get full text

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus by Passweg, Jakob R., Baldomero, Helen, Chabannon, Christian, Basak, Grzegorz W., Corbacioglu, Selim, Duarte, Rafael, Dolstra, Harry, Lankester, Arjan C., Mohty, Mohamad, Montoto, Silvia, Peffault de Latour, Régis, Snowden, John A., Styczynski, Jan, Yakoub-Agha, Ibrahim, Kröger, Nicolaus

“…Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the hematopoietic system. Number of transplants performed in…”
Get full text

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome by Guillaume, Thierry, Malard, Florent, Magro, Leonardo, Labopin, Myriam, Tabrizi, Reza, Borel, Cécile, Chevallier, Patrice, Vigouroux, Stéphane, Peterlin, Pierre, Garnier, Alice, Rubio, Marie-Thérèse, Huynh, Anne, Milpied, Noël, Moreau, Philippe, Gaugler, Béatrice, Yakoub-Agha, Ibrahim, Mohty, Mohamad

“…Thirty patients, with high-risk acute myeloid leukemia (AML, n  = 20) or myelodysplastic syndrome (MDS, n  = 10), were enrolled in a phase II trial entailing…”
Get full text

COVID-19 outcomes in patients with hematologic disease by Malard, Florent, Genthon, Alexis, Brissot, Eolia, van de Wyngaert, Zoe, Marjanovic, Zora, Ikhlef, Souhila, Banet, Anne, Lapusan, Simona, Sestilli, Simona, Corre, Elise, Paviglianiti, Annalisa, Adaeva, Rosa, M.’Hammedi-Bouzina, Fella, Labopin, Myriam, Legrand, Ollivier, Dulery, Rémy, Mohty, Mohamad

Get full text

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma by Perrot, Aurore, Lauwers-Cances, Valerie, Corre, Jill, Robillard, Nelly, Hulin, Cyrille, Chretien, Marie-Lorraine, Dejoie, Thomas, Maheo, Sabrina, Stoppa, Anne-Marie, Pegourie, Brigitte, Karlin, Lionel, Garderet, Laurent, Arnulf, Bertrand, Doyen, Chantal, Meuleman, Nathalie, Royer, Bruno, Eveillard, Jean-Richard, Benboubker, Lotfi, Dib, Mamoun, Decaux, Olivier, Jaccard, Arnaud, Belhadj, Karim, Brechignac, Sabine, Kolb, Brigitte, Fohrer, Cecile, Mohty, Mohamad, Macro, Margaret, Richardson, Paul G., Carlton, Victoria, Moorhead, Martin, Willis, Tom, Faham, Malek, Anderson, Kenneth C., Harousseau, Jean-Luc, Leleu, Xavier, Facon, Thierry, Moreau, Philippe, Attal, Michel, Avet-Loiseau, Hervé, Munshi, Nikhil

“…The introduction of novel agents has led to major improvements in clinical outcomes for patients with multiple myeloma. To shorten evaluation times for new…”
Get full text

Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients by Malard, Florent, Vekhoff, Anne, Lapusan, Simona, Isnard, Francoise, D’incan-Corda, Evelyne, Rey, Jérôme, Saillard, Colombe, Thomas, Xavier, Ducastelle-Lepretre, Sophie, Paubelle, Etienne, Larcher, Marie-Virginie, Rocher, Clément, Recher, Christian, Tavitian, Suzanne, Bertoli, Sarah, Michallet, Anne-Sophie, Gilis, Lila, Peterlin, Pierre, Chevallier, Patrice, Nguyen, Stéphanie, Plantamura, Emilie, Boucinha, Lilia, Gasc, Cyrielle, Michallet, Mauricette, Dore, Joel, Legrand, Ollivier, Mohty, Mohamad

“…Acute myeloid leukemia (AML) intensive chemotherapy combined with broad-spectrum antibiotics, leads to gut microbiota dysbiosis promoting pathological…”
Get full text

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies by Malard, Florent, Gaugler, Béatrice, Gozlan, Joel, Bouquet, Lucie, Fofana, Djeneba, Siblany, Lama, Eshagh, Deborah, Adotevi, Olivier, Laheurte, Caroline, Ricard, Laure, Dulery, Rémy, Stocker, Nicolas, van de Wyngaert, Zoe, Genthon, Alexis, Banet, Anne, Memoli, Mara, Ikhlef, Souhila, Sestilli, Simona, Vekhof, Anne, Brissot, Eolia, Marjanovic, Zora, Chantran, Yannick, Cuervo, Nancy, Ballot, Eric, Morand-Joubert, Laurence, Mohty, Mohamad

“…This study evaluated the safety and immunogenicity of BNT162b2 vaccine in patients with hematological malignancies. Antibodies blocking spike binding to…”
Get full text

New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia by Mohty, Razan, El Hamed, Rama, Brissot, Eolia, Bazarbachi, Ali, Mohty, Mohamad

“…The treatment of acute myeloid leukemia (AML) has evolved over the past few years with the advent of next-generation sequencing. Targeted therapies alone or in…”
Get full text

Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation by Battipaglia, Giorgia, Labopin, Myriam, Kröger, Nicolaus, Vitek, Antonin, Afanasyev, Boris, Hilgendorf, Inken, Schetelig, Johannes, Ganser, Arnold, Blaise, Didier, Itälä-Remes, Maija, Passweg, Jakob R., Bonifazi, Francesca, Finke, Jurgen, Ruggeri, Annalisa, Nagler, Arnon, Mohty, Mohamad

“…The use of anti-thymocyte globulin (ATG) has represented the standard of care in graft-versus-host disease (GVHD) prophylaxis in patients undergoing a…”
Get full text

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia by Schmid, Christoph, Labopin, Myriam, Schaap, Nicolaas, Veelken, Hendrik, Brecht, Arne, Stadler, Michael, Finke, Juergen, Baron, Frederic, Collin, Matthew, Bug, Gesine, Ljungman, Per, Blaise, Didier, Tischer, Johanna, Bloor, Adrian, Kulagin, Aleksander, Giebel, Sebastian, Gorin, Norbert-Claude, Esteve, Jordi, Ciceri, Fabio, Savani, Bipin, Nagler, Arnon, Mohty, Mohamad

“…We report on 318 patients with acute leukemia, receiving donor lymphocyte infusion (DLI) in complete hematologic remission (CHR) after allogeneic stem cell…”
Get full text

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors by Styczyński, Jan, Tridello, Gloria, Koster, Linda, Iacobelli, Simona, van Biezen, Anja, van der Werf, Steffie, Mikulska, Małgorzata, Gil, Lidia, Cordonnier, Catherine, Ljungman, Per, Averbuch, Diana, Cesaro, Simone, de la Camara, Rafael, Baldomero, Helen, Bader, Peter, Basak, Grzegorz, Bonini, Chiara, Duarte, Rafael, Dufour, Carlo, Kuball, Jurgen, Lankester, Arjan, Montoto, Silvia, Nagler, Arnon, Snowden, John A., Kröger, Nicolaus, Mohty, Mohamad, Gratwohl, Alois

“…Information on incidence, and factors associated with mortality is a prerequisite to improve outcome after hematopoietic stem cell transplantation (HSCT)…”
Get full text